| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/27/2013 | CN102988437A Panaxtrial saponins chewable tablet and preparation method thereof |
| 03/27/2013 | CN102988435A Traditional Chinese medicine preparation for senile headache caused by wind cold |
| 03/27/2013 | CN102988431A Health care product capable of improving reactivity |
| 03/27/2013 | CN102988417A Use of parasitic biological agents for diseases prevention and control |
| 03/27/2013 | CN102988403A Injection medicine composition used for treating facial paralysis in acute stage |
| 03/27/2013 | CN102988371A Kidney-warming and cold-dissipating tablet |
| 03/27/2013 | CN102988368A High-purity texaphyrin metal complex |
| 03/27/2013 | CN102988366A Use and nasal administration medicine of hydroxycamptothecine |
| 03/27/2013 | CN102988330A Novel nutraceuticalcompositions containing thymol and/or p-cymene or plant extracts for cognition |
| 03/27/2013 | CN102988323A Preparation method of aniracetam sustained-release tablet |
| 03/27/2013 | CN102988319A III crystal form pramipexole hydrochloride tablet and preparation method thereof |
| 03/27/2013 | CN102988315A Preparation method of agomelatine solid preparation |
| 03/27/2013 | CN102988309A Application of salvianolic acid A lyophilized powder in preparation of medicine for inhibiting brain tissueneuron damage or death |
| 03/27/2013 | CN102988304A Medicinal composition containing lysine hydrochloride compound |
| 03/27/2013 | CN102988292A Gypenoside lipidosome consisting of sterol and preparation method thereof |
| 03/27/2013 | CN102988284A Preparation method for monosialotetrahexosyl ganglioside sodium injection |
| 03/27/2013 | CN102987830A Chrysanthemum fragrant pillow |
| 03/27/2013 | CN102987377A Health care product with calming and nerve-soothing functions |
| 03/27/2013 | CN102987208A Preparation method of medicinal congee for treating insomnias |
| 03/27/2013 | CN102600153B Pediatric compound anisodamine hydrobromide and chlorpheniramine maleate freeze-dried orally disintegrating tablets and manufacturing method thereof |
| 03/27/2013 | CN102579374B Preparation process of penehyclidine hydrochloride powder for injection |
| 03/27/2013 | CN102416147B Medicinal composition for treating mania of patients abstained from drugs |
| 03/27/2013 | CN102389383B Perfume having anti-depression and refreshing functions and manufacturing method thereof |
| 03/27/2013 | CN102389382B Perfume having antianxiety and refreshing functions and manufacturing method thereof |
| 03/27/2013 | CN102366402B Scopolamine hydrobromide injection and production technology |
| 03/27/2013 | CN102363022B Chinese medicine for treating postpartum anemic fainting |
| 03/27/2013 | CN102357238B Traditional Chinese medicine combination for treating prosopalgia |
| 03/27/2013 | CN102357237B Chinese medicine composition for treating elderly intractable insomnia |
| 03/27/2013 | CN102349987B Traditional Chinese medicinal composition for treating epilepsy and preparation method thereof |
| 03/27/2013 | CN102335360B Chinese medicine for treating metal disorder |
| 03/27/2013 | CN102335338B Chinese medicinal compound preparation for improving parkinson disease brain neurotransmitter metabolism |
| 03/27/2013 | CN102335330B Traditional Chinese medicine composition for treating insomnia |
| 03/27/2013 | CN102335155B Quetiapine fumarate sustained-release tablets and preparation method thereof |
| 03/27/2013 | CN102276731B High-motion-activity polypeptide capable of inhibiting cocaine induction and application thereof |
| 03/27/2013 | CN102267971B Alicyclic-o[c] benzopyrone derivative and application thereof |
| 03/27/2013 | CN102266362B Method for extracting and refining cottonseed flavone from cottonseed shells |
| 03/27/2013 | CN102258548B Method for preparing nardostachyos root and rhizome volatile oil beta-cyclodextrin inclusion compound |
| 03/27/2013 | CN102250233B Royal jelly polypeptide and application thereof |
| 03/27/2013 | CN102240384B Medicament for treating phlegm-stasis accumulating type epilepsy and preparation method thereof |
| 03/27/2013 | CN102240287B Applications of gelsemine, koumine and 1-methoxyl gelsemine to preparation of medicine for treating anxiety |
| 03/27/2013 | CN102225197B Application and extraction method of acrosin |
| 03/27/2013 | CN102198171B Traditional Chinese medicine preparation for mainly treating angina, prosopalgia and headache, and preparation method thereof |
| 03/27/2013 | CN102180853B Anti-enterovirus 71 (EV71) flavonoid compound and application thereof to pharmacy |
| 03/27/2013 | CN102140466B Human miR-1825 antisense nucleic acid and application thereof |
| 03/27/2013 | CN102139094B Application of long-chain neurotoxin of cobra in preparation of muscarine type M4 receptor activator |
| 03/27/2013 | CN102119986B Traditional Chinese medicine extract with anti-dementia effect and preparation method thereof |
| 03/27/2013 | CN102100850B Quality control method for refined fructus forsythiae antidotal tablets |
| 03/27/2013 | CN102048837B Quality control method of baby protecting and convulsion relieving pills serving as Chinese medicinal preparation |
| 03/27/2013 | CN101921772B Human antibodies that bind human IL-12 and methods for producing |
| 03/27/2013 | CN101912615B Cladribine formulations for improved oral and transmucosal delivery |
| 03/27/2013 | CN101912397B Flupentixol composition |
| 03/27/2013 | CN101903347B Piperidinyl and piperazinyl modulators of gamma-secretase |
| 03/27/2013 | CN101903340B Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 03/27/2013 | CN101897953B Non-invasive high-penetrability epidermal growth factor and application thereof |
| 03/27/2013 | CN101797241B Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol |
| 03/27/2013 | CN101773641B Chinese medicine composition preparation for liver soothing and depression relief and quality control method |
| 03/27/2013 | CN101744787B Controlled release composite containing vinpocetine |
| 03/27/2013 | CN101679287B Nicotinic acetylcholine receptor modulators |
| 03/27/2013 | CN101627028B Substituted diazepan compounds as orexin receptor antagonists |
| 03/27/2013 | CN101622257B Polymorph b of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-n-methyl-acetamide |
| 03/27/2013 | CN101616902B 2-aminooxazolines as TAAR1 ligands |
| 03/27/2013 | CN101584869B Method of differentiating/inducing bone marrow interstitial cells into nerve cells and skeleton muscle cells by transferring notch gene |
| 03/27/2013 | CN101478977B Treatment of neurodegenerative diseases |
| 03/27/2013 | CN101448821B Carboxamide spirolactam cgrp receptor antagonists |
| 03/27/2013 | CN101442909B Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
| 03/27/2013 | CN101381409B N-terminally chemically modified protein compositions and methods |
| 03/27/2013 | CN101381408B Cobratide extraction method, cobratide extracted thereby and formulation containing cobratide |
| 03/27/2013 | CN101355940B In vivo or in vitro method for detecting amyloid deposits having at least one amyloidogenic protein |
| 03/27/2013 | CN101346154B Water-soluble films comprising low-viscosity alginates |
| 03/27/2013 | CN101277715B Treatment of neurodegenerative disorders |
| 03/27/2013 | CN101243056B Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 03/27/2013 | CN101194958B Method for preparing decocted ointment for treating headache |
| 03/27/2013 | CN101155804B Piperazine-substituted benzothiophenes for treatment of mental disorders |
| 03/27/2013 | CN101146786B Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 03/27/2013 | CN101137390B Novel angiogensis inhibitor |
| 03/27/2013 | CN101066997B Human antibodies that bind human IL-12 and methods for producing |
| 03/27/2013 | CA2790753A1 Prevention and treatment of pain using antibodies to sphingosine-1 phosphate |
| 03/26/2013 | US8404848 Derivatives of imidazo[1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics |
| 03/26/2013 | US8404737 Substituted isoindoline-1,3-dione derivatives |
| 03/26/2013 | US8404710 Phosphodiesterase 10A inhibitor |
| 03/26/2013 | US8404695 Pyrimidinyl pyridone inhibitors of JNK |
| 03/26/2013 | US8404675 Benzazepine derivatives and methods of prophylaxis or treatment of 5HT2C receptor associated diseases |
| 03/26/2013 | US8404459 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof |
| 03/26/2013 | US8404250 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 03/26/2013 | US8404226 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 03/26/2013 | CA2724151C Novel derivatives of azabicyclo[3.2.0]hept-3-yl, their preparation process and the pharmaceutical compounds that contain them |
| 03/26/2013 | CA2670284C Synthesis of compounds useful as modulators of amyloid-beta production |
| 03/26/2013 | CA2463850C Remodeling of tissues and organs |
| 03/26/2013 | CA2457925C Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 03/26/2013 | CA2424207C Stem cell differentiation-inducing promoter |
| 03/26/2013 | CA2262459C Gene involved in cadasil, method of diagnosis and therapeutic application |
| 03/23/2013 | CA2811188A1 Vaccine therapy |
| 03/21/2013 | WO2013040535A2 Bicarbocyclic and tricarbocyclic ethynyl derivatives and uses of same |
| 03/21/2013 | WO2013040501A1 Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes, and uses thereof |
| 03/21/2013 | WO2013040471A2 Noribogaine salt ansolvates |
| 03/21/2013 | WO2013039271A1 Brain-damage-induced frontal lobe dysfunction model animal and composition for alleviating frontal lobe dysfunction |
| 03/21/2013 | WO2013039140A1 Fused heterocyclic derivative |
| 03/21/2013 | WO2013039000A1 Pharmaceutical product for preventing or treating alzheimer's disease |
| 03/21/2013 | WO2013038666A1 Light-induced seizure model in rat brains |
| 03/21/2013 | WO2013038200A2 Neurodevelopmental disorders |